浙江昂利康制药股份有限公司 关于公司实际控制人股票质押式回购部分提前购回及进行股票质押式 回购交易且部分股份质押展期的公告

Core Points - The actual controller of Zhejiang Anglikang Pharmaceutical Co., Ltd., Mr. Lü Huaihao, has engaged in stock pledge repurchase transactions and has partially repurchased shares [1][2] - The pledged shares do not carry significant asset restructuring obligations or performance compensation liabilities [1][2] - The company confirms that Mr. Lü Huaihao has a good credit status and repayment capability, with no risk of forced liquidation or transfer of shares, ensuring no change in actual control [2] Summary by Sections - Share Pledge and Repurchase Details - Mr. Lü Huaihao has conducted stock pledge repurchase transactions with a repurchase date set for November 6, 2026 [1] - The pledged shares are not subject to major asset restructuring obligations [1] - Cumulative Pledge Situation - As of November 7, 2025, the total pledged shares by the shareholder and their concerted parties are documented, with specific details on the number of pledged and frozen shares [1] - Risk Assessment - The company will continue to monitor the changes in share pledges and associated risks, ensuring timely information disclosure [2]